Learn More
Medchemexpress LLC N-[2-amino-5-(2-thienyl)phenyl]-2-(1-piperazinyl)-6-quinolinecarboxamide | 1609389-52-7 | 99.6% | 429.54 g/mol | C24H23N5OS | 1 ML

Supplier: Medchemexpress LLC HY10400810MM 1ML
ACY-957 is an orally active, selective small-molecule inhibitor of histone deacetylases HDAC1 and HDAC2 used in preclinical research to modulate epigenetic regulation and induce fetal hemoglobin expression. Reported IC50 values are 7 nM (HDAC1), 18 nM (HDAC2), and 1,300 nM (HDAC3). Supplied for in vitro and in vivo studies.
- Selective inhibition of HDAC1 and HDAC2 with low-nanomolar potency.
- Demonstrated activity in cellular models of globin gene induction.
- Orally active in preclinical pharmacology studies.
- Suitable for both in vitro and in vivo research applications.
- Characterized with vendor-provided purity and analytical data.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.